JP2014510763A5 - - Google Patents

Download PDF

Info

Publication number
JP2014510763A5
JP2014510763A5 JP2014504131A JP2014504131A JP2014510763A5 JP 2014510763 A5 JP2014510763 A5 JP 2014510763A5 JP 2014504131 A JP2014504131 A JP 2014504131A JP 2014504131 A JP2014504131 A JP 2014504131A JP 2014510763 A5 JP2014510763 A5 JP 2014510763A5
Authority
JP
Japan
Prior art keywords
growth factor
composition
carrier
kit
period
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014504131A
Other languages
English (en)
Japanese (ja)
Other versions
JP6224579B2 (ja
JP2014510763A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2012/050234 external-priority patent/WO2012139223A1/en
Publication of JP2014510763A publication Critical patent/JP2014510763A/ja
Publication of JP2014510763A5 publication Critical patent/JP2014510763A5/ja
Application granted granted Critical
Publication of JP6224579B2 publication Critical patent/JP6224579B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014504131A 2011-04-11 2012-04-11 増殖因子の多相放出を行うためのシステムおよび方法 Active JP6224579B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161474049P 2011-04-11 2011-04-11
US61/474,049 2011-04-11
PCT/CA2012/050234 WO2012139223A1 (en) 2011-04-11 2012-04-11 System and method for multiphasic release of growth factors

Publications (3)

Publication Number Publication Date
JP2014510763A JP2014510763A (ja) 2014-05-01
JP2014510763A5 true JP2014510763A5 (cg-RX-API-DMAC10.html) 2015-05-28
JP6224579B2 JP6224579B2 (ja) 2017-11-01

Family

ID=47008753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014504131A Active JP6224579B2 (ja) 2011-04-11 2012-04-11 増殖因子の多相放出を行うためのシステムおよび方法

Country Status (11)

Country Link
US (5) US9675670B2 (cg-RX-API-DMAC10.html)
EP (1) EP2696852B1 (cg-RX-API-DMAC10.html)
JP (1) JP6224579B2 (cg-RX-API-DMAC10.html)
CN (1) CN103596553B (cg-RX-API-DMAC10.html)
AU (2) AU2012243410B8 (cg-RX-API-DMAC10.html)
BR (2) BR112013026241A2 (cg-RX-API-DMAC10.html)
CA (1) CA2833023C (cg-RX-API-DMAC10.html)
DK (1) DK2836195T3 (cg-RX-API-DMAC10.html)
RU (2) RU2017134806A (cg-RX-API-DMAC10.html)
WO (1) WO2012139223A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201307453B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140271471A1 (en) * 2013-03-14 2014-09-18 Genzyme Corporation Thermo-sensitive bone growth compositions
PT3116521T (pt) 2014-03-14 2024-10-15 Univ New York State Res Found Regulação neurogénica de crescimento ósseo e degradação óssea
CN104894069B (zh) * 2015-05-07 2019-07-12 中国人民解放军第四军医大学 一种光控胰岛素节律性分泌的组织工程装置
CN107412859B (zh) * 2017-04-26 2020-07-14 温州医科大学附属口腔医院 一种双基因时序性缓释的组织工程支架材料的制备方法
RU2665155C1 (ru) * 2018-01-10 2018-08-28 федеральное государственное бюджетное образовательное учреждение высшего образования "Приволжский исследовательский медицинский университет" Министерства здравоохранения Российской Федерации Способ доставки биологически активных веществ в скаффолд
CN109568670B (zh) * 2018-10-24 2021-05-07 温州医科大学 一种子宫内膜损伤修复的水凝胶及其制备方法
CA3124677A1 (en) 2018-12-25 2020-07-02 Orthorebirth Co., Ltd. A bone regeneration material having a cotton-wool like structure formed of a plurality of electrospun fibers
WO2020232436A1 (en) 2019-05-16 2020-11-19 Brown University A human in vitro cardiotoxicity model
GB202106973D0 (en) * 2021-05-14 2021-06-30 Locate Bio Ltd Osteoconductive implant material with BMP-2 delivery
US12076437B2 (en) 2021-07-12 2024-09-03 Brown University Proangiogenic protein cocktails delivered in custom biomaterials to revascularize ischemic tissue
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789732A (en) 1980-08-04 1988-12-06 Regents Of The University Of California Bone morphogenetic protein composition
US4761471A (en) 1980-08-04 1988-08-02 The Regents Of The University Of California Bone morphogenetic protein composition
US4795804A (en) 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
US4857456A (en) 1985-04-30 1989-08-15 The Regents Of The University Of California Assay of Bone morphogenetic protein (BMP) and anti-BMP antibody for the diagnosis of bone disorders
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US5631142A (en) 1986-07-01 1997-05-20 Genetics Institute, Inc. Compositions comprising bone morphogenetic protein-2 (BMP-2)
US4877864A (en) 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
KR100259827B1 (ko) 1991-11-04 2000-06-15 브루스 엠. 에이센, 토마스 제이 데스로저 재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법
US5385887A (en) 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
GB9415810D0 (en) * 1994-08-04 1994-09-28 Jerrow Mohammad A Z Composition
AU6267798A (en) 1997-02-07 1998-08-26 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
DE60017363T2 (de) 1999-02-02 2006-03-02 Wright Medical Technology Inc., Arlington Kontrollierte freisetzung eines verbundmaterials
US6998137B2 (en) 2000-04-07 2006-02-14 Macromed, Inc. Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
US6589549B2 (en) * 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
US20070190102A1 (en) 2000-06-30 2007-08-16 Ping Luo Method of preparing hydroxyapatite based drug delivery implant for infection and cancer treatment
US6503109B1 (en) 2000-07-19 2003-01-07 Marshall D. Duffield Swivel drive assembly
US20080233165A1 (en) 2000-08-07 2008-09-25 Biolok International, Inc. Time release calcium sulfate and growth factor matrix for bone augmentation
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
US7671012B2 (en) * 2004-02-10 2010-03-02 Biosurface Engineering Technologies, Inc. Formulations and methods for delivery of growth factor analogs
CN1267590C (zh) * 2004-06-11 2006-08-02 清华大学 一种用于组织修复的生长因子缓释体系的制备方法
US7325262B2 (en) 2005-03-02 2008-02-05 Standard Textile Co., Inc. Bedding hem with associated interlining
EP1893174A2 (en) 2005-05-10 2008-03-05 Cytophil, Inc. Injectable hydrogels and methods of making and using same
US20060257492A1 (en) * 2005-05-13 2006-11-16 Depuy Products, Inc. Suspension of calcium phosphate particulates for local delivery of therapeutic agents
CN1733311A (zh) * 2005-08-18 2006-02-15 同济大学 一种包裹药物或生长因子的纳米纤维的制备方法
US20070248675A1 (en) 2005-09-08 2007-10-25 Gwangju Institute Of Science And Technology Composite comprising polysaccharide-functionalized nanoparticle and hydrogel matrix, a drug delivery system and a bone defect replacement matrix for sustained release comprising the same, and the preparation method thereof
US20070255422A1 (en) 2006-04-25 2007-11-01 Mei Wei Calcium phosphate polymer composite and method
US20090264489A1 (en) 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
CA2653866A1 (en) * 2008-07-03 2010-01-03 Induce Biologics Inc. Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness
US9492375B2 (en) * 2008-07-23 2016-11-15 Warsaw Orthopedic, Inc. Foam carrier for bone grafting
US20110208305A1 (en) 2008-08-05 2011-08-25 University Of Miami Composite bone grafts, particulate bone-calcium sulfate constructs, and methods of treating joint injuries
US20110027331A1 (en) * 2009-07-29 2011-02-03 Warsaw Orthopedic, Inc. An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation

Similar Documents

Publication Publication Date Title
RU2017134806A (ru) Система и способ многофазного высвобождения факторов роста
Douglas et al. Splicing therapy for neuromuscular disease
Yuan et al. Dual‐controlled release of icariin/Mg2+ from biodegradable microspheres and their synergistic upregulation effect on bone regeneration
King et al. Growth factor delivery: how surface interactions modulate release in vitro and in vivo
Samorezov et al. Spatial regulation of controlled bioactive factor delivery for bone tissue engineering
Yao et al. Hypoxia-mimicking nanofibrous scaffolds promote endogenous bone regeneration
FI2234617T4 (fi) Pitkävaikutteisiin injektoitaviin paliperidoniestereihin liittyvä annosteluohjelma
NZ607797A (en) Corticosteroids for the treatment of joint pain
MY169349A (en) Biodegradable, semi-crystalline, phase separated, thermoplastic multi-block copolymers for controlled release of biologically active compounds
PH12014502668B1 (en) Paliperidone implant formulation
MX374955B (es) Formulación de implantes de risperidona o paliperidona.
Wang et al. Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials
Lee et al. Size-controlled human adipose-derived stem cell spheroids hybridized with single-segmented nanofibers and their effect on viability and stem cell differentiation
Chen et al. Nanofibers used for delivery of antimicrobial agents
US11135340B2 (en) Compositions and methods for preparation of composite polymer coatings on medical implants, and their use for co-delivery of multiple antimicrobial agents
JP2011503213A5 (cg-RX-API-DMAC10.html)
WO2013036309A3 (en) Sustained release formulations for delivery of proteins to the eye and methods of preparing same
FI3858375T3 (fi) Hyytymishäiriön hoito antamalla rekombinanttia von Willebrand -tekijää
Rutledge et al. Modulation of inflammatory response and induction of bone formation based on combinatorial effects of resveratrol
Shin et al. Mussel adhesion‐inspired reverse transfection platform enhances osteogenic differentiation and bone formation of human adipose‐derived stem cells
JP2016506923A5 (cg-RX-API-DMAC10.html)
JP2015516387A5 (cg-RX-API-DMAC10.html)
PL2201940T3 (pl) Kompozycja biokompatybilnych mikrocząstek kwasu alginowego do kontrolowanego uwalniania substancji czynnej po podaniu dożylnym
RU2014145234A (ru) Система и способ для многофазного высвобождения факторов роста
Khunmanee et al. Effective wound healing on diabetic mice by adhesive antibacterial GNPs-lysine composited hydrogel